Back to Search
LAUREN PRENTICE, PHARMD
PHARMD
Pharmacist
NPI: 1639404049Individual
Specialties, Licenses & Credentials
Research & Publications (12)
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.
PMID 18005407·BMC Med·2007
8-other
Ion leaching of a glass-ionomer glass: an empirical model and effects on setting characteristics and strength.
PMID 17200822·J Mater Sci Mater Med·2007
8-other
The effect of oxalic acid incorporation on the setting time and strength of a glass-ionomer cement.
PMID 16701865·Acta Biomater·2006
8-other
The effect of ytterbium fluoride and barium sulphate nanoparticles on the reactivity and strength of a glass-ionomer cement.
PMID 16364424·Dent Mater·2006
8-other
The effects of boric acid and phosphoric acid on the compressive strength of glass-ionomer cements.
PMID 16045978·Dent Mater·2006
8-other
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
PMID 16027731·Oncogene·2005
4-observational
The effect of mixing time on the handling and compressive strength of an encapsulated glass-ionomer cement.
PMID 16026665·Dent Mater·2005
8-other
The effect of particle size distribution on an experimental glass-ionomer cement.
PMID 15904692·Dent Mater·2005
8-other
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
PMID 19053170·PLoS Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 5717 S NC 41 HWY
WALLACE, NC 28466 - Phone
- (910) 285-6481
Quick Facts
- NPI
- 1639404049
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile